Strategic Plan Objective Detail
Interagency Autism Coordinating Committee (IACC) logo
Office of Autism Research Coordination (OARC) logo

Question 4: Objective 8  

$1,380,376.00
Fiscal Year: 2008

Yellow dot: Objective has some degree of funding, but less than the recommended amount.4.8 Complete at least three randomized controlled trials on medications targeting core symptoms in people with ASD of all ages by 2014. IACC Recommended Budget: $22,200,000 over 5 years.

Download 2008 Question 4: Objective 8 projects (EXCEL)
Note: Initial Sort is by Principal Investigator. Sorting by other columns is available by clicking on the desired column header.
Project Title Principal Investigator Institution
Intransal oxytocin in the treatment of autism Anagnostou, Athanasius Mount Sinai School of Medicine
Oxytocin vs placebo on response inhibition & face processing in autism Anagnostou, Athanasius Mount Sinai School of Medicine
Neuronal nicotonic receptor modulation in the treatment of autism: A pilot trial of mecamylamine Arnold, L. Eugene The Ohio State University
A randomized, double blind, placebo controlled study of fatty acid supplementation in autism Carpenter, Laura Medical University of South Carolina
Double-blind placebo controlled trial of subcutaneous methyl B12 on behavioral and metabolic measures in children with autism Hendren, Robert University of California, Davis
Divalproex sodium ER in adult autism Hollander, Eric Mount Sinai School of Medicine
Understanding repetitive behavior in autism McCracken, James University of California, Los Angeles
Aripiprazole in children and adolescents with autistic disorder McDougle, Christopher Indiana University-Purdue University Indianapolis
Risperidone and behavior therapy in children and adolescents with pervasive disorder McDougle, Christopher Indiana University-Purdue University Indianapolis
The pharmacognetics of treatment for insistence sameness in autism Owley, Thomas University of Illinois at Chicago
D-cycloserine in children and adolescents with autism Posey, David Indiana University-Purdue University Indianapolis
Double masked placebo controlled trial of cholesterol in hypocholesterolemic ASD Tierney, Elaine Kennedy Krieger Institute